DRS — Leonardo DRS, Inc.

Summary of DRS Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Q4 Revenue: $1.1 billion, up 8% year-over-year.
• Full-Year Revenue: $3.6 billion, representing 13% organic growth, marking back-to-back years of double-digit growth.
• Adjusted EBITDA: $158 million for Q4 and $453 million for the full year, with year-over-year growth of 7% and 13%, respectively. Full-year margin remained flat at 12.4%.
• Diluted EPS: Increased by 15% in Q4 and 29% for the full year.
• Free Cash Flow: $376 million in Q4, totaling $227 million for the year, reflecting a 19% increase in full-year free cash flow.
• Year-End Backlog: $8.7 billion, providing visibility into 2026 growth.

2. Strategic Updates and Business Highlights:

• John Baylouny took over as CEO, emphasizing a focus on innovation, operational efficiency, and employee empowerment.
• The company reported a fourth consecutive year of a book-to-bill ratio of 1.2 or better, indicating strong demand across its portfolio.
• Significant investments were made in R&D (up 40%) and capital expenditures (up over 60%) to support growth in high-demand areas such as airborne, missiles, space, and unmanned markets.
• Notable wins included a position on the SDA Tracking Layer Tranche 3 program and advancements in secure satellite communications and infrared sensing technologies.
• The company is enhancing its capabilities in counter-UAS and tactical radars, responding to increasing global demand.

3. Forward Guidance and Outlook:

• 2026 Revenue Guidance: Expected to be between $3.85 billion and $3.95 billion, implying 6% to 8% organic growth.
• Adjusted EBITDA Guidance: Projected between $500 million and $525 million, with an anticipated margin improvement of 70 to 90 basis points.
• CapEx Expectations: Anticipated to be around 5% of revenue, reflecting continued investment in capacity and capability enhancements.
• Q1 Revenue Guidance: Expected to be in the low $800 million range with adjusted EBITDA margins in the low 11% range.

4. Bad News, Challenges, or Points of Concern:

• The company faced supply chain complexities, particularly related to germanium shortages, although remediation measures are in place.
• The conclusion of a legacy foreign ground surveillance program resulted in an unanticipated loss, though management indicated this was an isolated incident.
• Increased R&D investments created a 70 basis point headwind to margins, which may continue to impact profitability in the near term.
• There are concerns about the pace of material receipts and labor execution affecting revenue growth.

5. Notable Q&A Insights:

• Management acknowledged the potential for increased defense spending due to recent appropriations but noted that the flow of funds to customers is still in early stages.
• The company is optimistic about growth but recognizes that diverse portfolio elements may grow at different rates, with some areas potentially experiencing slower growth.
• Discussions around European defense spending and opportunities were highlighted, with management expressing confidence in leveraging partnerships for growth.
• The quantum laser license agreement was discussed as a strategic move to focus on core defense capabilities while monetizing non-core technologies.
• Management emphasized a disciplined approach to capital deployment, prioritizing organic investments before considering acquisitions.

Overall, DRS demonstrated strong financial performance in 2025, with a positive outlook for 2026 despite some challenges in supply chain and program transitions. The company remains committed to innovation and growth in defense capabilities.